Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT)
Authors:
- Xiaobo PengXPXiaobo Peng
- Yanqing LiuYLYanqing Liu
- Yawei SunYSYawei Sun
- Xingwang WangXWXingwang Wang
- Guodong LinGLGuodong Lin
- Peng ZhangPZPeng Zhang
- Kun WanKWKun Wan
- Zewu QiuZQZewu Qiu
Open Access
- 1 August 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (34) , e10659
Abstract
This study was conducted to analyze the clinical characteristics of and treatment strategies for botulism among patients receiving cosmetic injection of botulinum toxin (BoNT). A total of 86 botulism patients caused by cosmetic injection of BoNT were enrolled in our study. All of the patients were diagnosed according to their history of cosmetic BoNT injection, clinical symptoms and signs, and other auxiliary examinations (including those on renal and liver functions, blood index detection, and chest X-ray). All of the patients received comprehensive treatments and botulinum antitoxin serum injection. The main symptoms of botulism patients included headache, dizziness, insomnia, fatigue, blurred vision, eye opening difficulty, slurred speech, dysphagia, bucking, constipation, and anxiety. These clinical symptoms occurred 0∼36 days after BoNT injection, especially from 2nd to 6th day after the operation. Furthermore, the usage dose of BoNT was negatively related to latent period. Finally, patients all discharged from our hospital 1∼20 days after treatments, and their symptoms relieved or disappeared. Botulism is a severe side effect for BoNT injection. Injecting botulinum antitoxin serum may be an effective approach to improve clinical outcomes of botulism cases.Keywords
This publication has 17 references indexed in Scilit:
- Botulinum Toxin for Neuropathic Pain: A Review of the LiteratureToxins, 2015
- A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A AntitoxinThe Journal of Infectious Diseases, 2015
- Botulinum Toxin for the Treatment of Refractory Erythema and Flushing of RosaceaDermatology, 2015
- Botulinum toxin therapy for hyperhidrosis: reduction of injection site pain by nitrous oxide/oxygen mixturesJournal of Neural Transmission, 2015
- Serious and Long-Term Adverse Events Associated with the Therapeutic and Cosmetic Use of Botulinum ToxinPharmacology, 2015
- Toxins as Weapons: A Historical Review.2014
- Long-term outcomes of balloon dilation versus botulinum toxin injection in patients with primary achalasiaThe Korean Journal of Internal Medicine, 2014
- Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: A retrospective studyJournal of the Chinese Medical Association, 2014
- Differences in immunological responses of polyclonal botulinum A1 and A2 antitoxin against A1 and A2 toxinToxicon, 2013
- The Use of Botulinum Toxin to Treat Strabismus Following Retinal Detachment SurgeryStrabismus, 2013